Medical Imaging & Therapy using Synchrotron Radiation

A talk by Dr Alberto Bravin

CSIRO MSE, the Australian Synchrotron, and the Monash Centre for Synchrotron Science are co-hosting a seminar on recent developments in imaging and therapy at the European Synchrotron Radiation Facility, on Friday April 11 2008 at Monash's Clayton campus:

The scientific programs at the ID17 biomedical beamline of the ESRF: medical imaging and radiotherapy clinical trials

Dr Alberto Bravin
Scientist and Managing Physicist
Biomedical Beamline ID17
European Synchrotron Radiation Facility


Lecture Theatre S3, Building 25, Monash University, Clayton Campus



Biomedical programs at the ESRF-ID17 beamline are focused on medical radiology and radiotherapy. Innovative imaging techniques are developed and exploited in in-vivo and in-vitro models and in a wide range of scientific cases; the clinical application of the findings is always considered as the driving objective. In this context, the beamline’s activities are now focused on functional (e.g. lung and brain) and anatomical (e.g. breast and cartilage pathology) imaging, and in the visualization of nanoparticle-based contrast agents. If all imaging programs are presently in the preclinical phase, the radiation therapy programs, namely the Microbeam Radiation Therapy (which uses spatially fractionated white X-ray beams delivered in extremely high doses) and the Stereotactic Synchrotron Radiation Therapy (which uses monochromatic X-rays targeting high Z elements inoculated into the tumours) are fast moving towards the clinical phase. A review of the latest achievements and the short-medium term perspectives of the ID17 programs will be presented and discussed.

Map available from:

Attention: open in a new window. PDFPrintE-mail